FDA Approves Regeneron's Otarmeni, First Gene Therapy for Genetic Hearing Loss

Audiologists and ENT teams treating patients with the relevant genetic form of hearing loss should become familiar with Otarmeni's approved indication and refer eligible patients to gene therapy specialists; this is a practice-changing regulatory milestone.